X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
male (34) 34
middle aged (31) 31
female (29) 29
respiratory system (28) 28
adult (25) 25
aged (24) 24
copd (24) 24
asthma (22) 22
index medicus (21) 21
pulmonary disease, chronic obstructive - drug therapy (21) 21
obstructive pulmonary-disease (20) 20
double-blind method (18) 18
tiotropium (18) 18
treatment outcome (15) 15
cross-over studies (13) 13
lung diseases, obstructive (13) 13
chronic obstructive pulmonary disease (12) 12
respiratory tract diseases (12) 12
administration, inhalation (11) 11
efficacy (11) 11
pulmonary disease, chronic obstructive - physiopathology (11) 11
research (11) 11
drug therapy (10) 10
pulmonary and respiratory medicine (10) 10
time factors (10) 10
bronchodilator agents - administration & dosage (9) 9
bronchodilator agents - therapeutic use (9) 9
diseases of the respiratory system (9) 9
exacerbations (9) 9
inflammation (9) 9
severity of illness index (9) 9
tiotropium bromide (9) 9
allergy (8) 8
asthma - drug therapy (8) 8
drug administration schedule (8) 8
forced expiratory volume (8) 8
indacaterol (8) 8
original research (8) 8
scopolamine derivatives - therapeutic use (8) 8
immunology (7) 7
pharmacology & pharmacy (7) 7
pulmonary disease, chronic obstructive - diagnosis (7) 7
asthma - diagnosis (6) 6
bronchodilator agents - adverse effects (6) 6
cardiac & cardiovascular systems (6) 6
care and treatment (6) 6
induced sputum (6) 6
lung - physiopathology (6) 6
olodaterol (6) 6
sputum - chemistry (6) 6
adolescent (5) 5
asthma - immunology (5) 5
clinical trials (5) 5
international journal of chronic obstructive pulmonary disease (5) 5
lung - drug effects (5) 5
pharmaceutical industry (5) 5
sputum - cytology (5) 5
trial (5) 5
adrenergic beta-2 receptor agonists - therapeutic use (4) 4
albuterol - analogs & derivatives (4) 4
albuterol - therapeutic use (4) 4
allergens (4) 4
asthma - metabolism (4) 4
asthma - physiopathology (4) 4
benzoxazines - administration & dosage (4) 4
bronchitis (4) 4
bronchodilator (4) 4
cytokines (4) 4
deficiency (4) 4
dosage and administration (4) 4
double-blind (4) 4
drug combinations (4) 4
exercise (4) 4
exercise tolerance - drug effects (4) 4
fev1 (4) 4
forced expiratory volume - drug effects (4) 4
glutathione (4) 4
glycopyrrolate - administration & dosage (4) 4
glycopyrrolate - adverse effects (4) 4
indans - therapeutic use (4) 4
interleukin-8 - analysis (4) 4
lung function (4) 4
medical and health sciences (4) 4
medical research (4) 4
medicin och hälsovetenskap (4) 4
medicine, research & experimental (4) 4
muscarinic antagonists - administration & dosage (4) 4
muscarinic antagonists - adverse effects (4) 4
oncology (4) 4
pharmacokinetics (4) 4
prevention (4) 4
pulmonary/respiratory (4) 4
quinolones - therapeutic use (4) 4
respiratory agents (4) 4
safety (4) 4
salmeterol (4) 4
salmeterol xinafoate (4) 4
sputum - immunology (4) 4
studies (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of COPD, ISSN 1176-9106, 11/2016, Volume 11, Issue 1, pp. 2910 - 2911
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 12, pp. 1093 - 1103
Journal Article
International Journal of Chronic Obstructive Pulmonary Disease, ISSN 1178-2005, 01/2016, Volume 11, Issue 1, p. 2910
Journal Article
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 10/2016, Volume 29, Issue 5, pp. 406 - 415
Background: This study was conducted to confirm the 24-hour bronchodilator efficacy and pharmacokinetic profile of once-daily tiotropium Respimat registered 5... 
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2014, Volume 108, Issue 4, pp. 584 - 592
Summary Introduction QVA149 is a novel, inhaled, once-daily dual bronchodilator containing a fixed-dose combination of the long-acting β2 -agonist indacaterol... 
Pulmonary/Respiratory | QVA149 | Tiotropium | Chronic obstructive pulmonary disease | Exercise | Hyperinflation | PLACEBO | CARDIAC & CARDIOVASCULAR SYSTEMS | DAILY NVA237 | EFFICACY | SAFETY | BRONCHODILATION | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | TWICE-DAILY SALMETEROL | ONCE-DAILY INDACATEROL | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Exercise Tolerance - drug effects | Indans - therapeutic use | Lung Volume Measurements | Vital Capacity - drug effects | Quinolones - adverse effects | Spirometry - methods | Quinolones - therapeutic use | Adult | Female | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Tiotropium Bromide | Glycopyrrolate - adverse effects | Double-Blind Method | Drug Administration Schedule | Glycopyrrolate - therapeutic use | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Cross-Over Studies | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Aged | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Medical research | Lung diseases, Obstructive | Confidence intervals | Drug therapy
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 3, pp. 866 - 874
Journal Article
Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 03/2013, Volume 131, Issue 3, pp. 866 - 874
Background: Allergen-specific TH2 responses contribute to the development of allergic asthma. Their increase may be due to a reduced early exposure to... 
Pathogens | Inventories | Hypersensitivity | Leukocytes (eosinophilic) | Phages | Helper cells | Clinical trials | salbutamol | Lymphocytes T | Nighttime | Blood | TLR9 protein | Virus-like particles | Asthma | Nitric oxide | Toll-like receptors | Steroid hormones | Immune system
Journal Article
Respiratory Research, ISSN 1465-9921, 08/2015, Volume 16, Issue 1
Olodaterol is a novel, inhaled long-acting [beta].sub.2-agonist (LABA) with >24-hour duration of action investigated in asthma and chronic obstructive... 
Care and treatment | Analysis | Pulmonary function tests | Asthma
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2015, Volume 32, pp. 53 - 59
Journal Article
International Journal of COPD, ISSN 1176-9106, 2012, Volume 7, pp. 503 - 513
Journal Article
International Journal of Chronic Obstructive Pulmonary Disease, ISSN 1178-2005, 04/2011, p. 237
Journal Article
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ISSN 1178-2005, 2016, Volume 11, pp. 193 - 205
Journal Article